𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetic, histopathologic, and immunologic studies of multifocal renal cell carcinoma

✍ Scribed by Kerstin Junker; Andreas Schlichter; Udo Junker; Brigitte Knöfel; Hartwig Kosmehl; Jörg Schubert; Uwe Claussen

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
180 KB
Volume
79
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Multifocal tumor areas occurred in 12 -22% of patients with renal

📜 SIMILAR VOLUMES

Biologic behavior of and p53 overexpress
Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type : An immunohistochemical study correlating grading, staging, and proliferation markers
✍ Andrea Haitel; Helene G. Wiener; Ulrike Blaschitz; Michael Marberger; Martin Sus 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

## BACKGROUND. In the treatment of small renal cell carcinoma (RCC), there is controversy between radical and nephron-sparing surgical treatment because of the risk of tumor multifocality. The biologic behavior of multifocal RCC compared with that of unifocal RCC is not well investigated, and the

Improving the prognostic value of histop
Improving the prognostic value of histopathological grading and clinical staging in renal cell carcinomas by means of computer-assisted microscopy
✍ Francois, Christine; Decaestecker, Christine; de Lathouwer, Oliver; Moreno, Chri 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

The present work aims to refine prognosis in cases of renal cell carcinoma (RCC) by integrating a variety of parameters with the prognostic information provided by histopathological grading and clinical staging, carried out on a series of 97 RCCs. To this end, Feulgen-stained RCC cell nuclei were ch

A phase II trial of interferon-α and 5-f
A phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
✍ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

Evaluation of low dose continuous infusi
Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study
✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology